Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Associations between adverse pregnancy outcomes and cognitive impairment and dementia: a systematic review and meta-analysis

EC. Miller, P. Conley, M. Alirezaei, K. Wolfova, MM. Gonzales, ZS. Tan, SE. Tom, LM. Yee, AM. Brickman, NA. Bello

. 2024 ; 5 (12) : 100660. [pub] 20241212

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, systematický přehled, metaanalýza

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003126

Grantová podpora
K23 HL136853 NHLBI NIH HHS - United States
K23 NS107645 NINDS NIH HHS - United States
R01 AG085475 NIA NIH HHS - United States
R01 NS122815 NINDS NIH HHS - United States

BACKGROUND: Individuals with adverse pregnancy outcomes have an increased risk of cerebrovascular disease, but the association between adverse pregnancy outcomes and cognitive impairment and dementia is less well established. We aimed to synthesise, combine, and assess the growing body of data examining the associations between adverse pregnancy outcomes and mild cognitive impairment and dementia in parous women. METHODS: In this systematic review and meta-analysis, we searched PubMed (MEDLINE), Web of Science, and Embase from database inception up to July 18, 2024, with no language restrictions, for observational studies or clinical trials that reported mild cognitive impairment or dementia as outcomes and included female individuals or women who had an adverse pregnancy outcome, including hypertensive disorders of pregnancy, gestational diabetes, stillbirth, fetal growth restriction, preterm birth, or placental abruption. We excluded studies of men, nulliparous women, women with pre-pregnancy conditions associated with impaired cognition, and studies examining cognitive impairment within 6 months of pregnancy. Database searches were supplemented by manual review of the reference lists of included studies. If studies met eligibility criteria but did not have sufficient data for meta-analysis (ie, did not report a summary statistic or a hazard ratio [HR] for outcome estimation), they were included in the systematic review and excluded from the meta-analysis. After removing duplicates, two investigators independently screened titles and abstracts using Covidence software, with potentially eligible studies undergoing full-text review by the same reviewers, with further review by a third reviewer and disagreements resolved by discussion and group consensus. Study quality was assessed and summary statistics extracted by two reviewers independently. The primary outcomes of our study were mild cognitive impairment, all-cause dementia, Alzheimer's disease, and vascular dementia. Heterogeneity was measured using the Q test and I2 statistic, and we used random-effects models with inverse-variance weighting to assess the association between adverse pregnancy outcome and primary outcomes with sufficient meta-analysable data via pooled adjusted HRs and 95% CIs. The study protocol was registered with PROSPERO, CRD42023453511. FINDINGS: Of 11 251 publications identified, 15 studies (including 7 347 202 participants) met inclusion criteria for the systematic review, and 11 studies (6 263 431 participants) had sufficient data for meta-analysis. A history of any adverse pregnancy outcome was associated with higher risk of all-cause dementia (adjusted HR 1·32 [95% CI 1·17-1·49]; I2= 80%), Alzheimer's disease (1·26 [1·04-1·53]; I2=63%), and vascular dementia (1·94 [1·70-2·21]; I2=0%). A history of any hypertensive disorder of pregnancy was significantly associated with all-cause dementia (1·32 [1·11-1·57]; I2=74%) and vascular dementia (1·78 [1·46-2·17]; I2=0%), but not Alzheimer's disease (1·24 [0·98-1·57]; I2=66%). Stillbirth was not significantly associated with higher risk of all-cause dementia (1·26 [95% CI 0·93-1·71]; I2=62%). In individual studies, similar effect directions were observed for preterm birth and fetal growth restriction, but data were insufficient for meta-analysis. INTERPRETATION: Given their increased risk of dementia, women with a history of adverse pregnancy outcomes should be evaluated for additional dementia risk factors and monitored closely for any signs of cognitive decline. Furthermore, to obtain more reliable findings, future studies should measure both exposures and outcomes prospectively and objectively. FUNDING: National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Institute on Aging, and National Heart, Lung and Blood Institute.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003126
003      
CZ-PrNML
005      
20250206104044.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.lanhl.2024.100660 $2 doi
035    __
$a (PubMed)39675366
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Miller, Eliza C $u Department of Neurology, Columbia University, New York, NY, USA. Electronic address: ecm2137@cumc.columbia.edu
245    10
$a Associations between adverse pregnancy outcomes and cognitive impairment and dementia: a systematic review and meta-analysis / $c EC. Miller, P. Conley, M. Alirezaei, K. Wolfova, MM. Gonzales, ZS. Tan, SE. Tom, LM. Yee, AM. Brickman, NA. Bello
520    9_
$a BACKGROUND: Individuals with adverse pregnancy outcomes have an increased risk of cerebrovascular disease, but the association between adverse pregnancy outcomes and cognitive impairment and dementia is less well established. We aimed to synthesise, combine, and assess the growing body of data examining the associations between adverse pregnancy outcomes and mild cognitive impairment and dementia in parous women. METHODS: In this systematic review and meta-analysis, we searched PubMed (MEDLINE), Web of Science, and Embase from database inception up to July 18, 2024, with no language restrictions, for observational studies or clinical trials that reported mild cognitive impairment or dementia as outcomes and included female individuals or women who had an adverse pregnancy outcome, including hypertensive disorders of pregnancy, gestational diabetes, stillbirth, fetal growth restriction, preterm birth, or placental abruption. We excluded studies of men, nulliparous women, women with pre-pregnancy conditions associated with impaired cognition, and studies examining cognitive impairment within 6 months of pregnancy. Database searches were supplemented by manual review of the reference lists of included studies. If studies met eligibility criteria but did not have sufficient data for meta-analysis (ie, did not report a summary statistic or a hazard ratio [HR] for outcome estimation), they were included in the systematic review and excluded from the meta-analysis. After removing duplicates, two investigators independently screened titles and abstracts using Covidence software, with potentially eligible studies undergoing full-text review by the same reviewers, with further review by a third reviewer and disagreements resolved by discussion and group consensus. Study quality was assessed and summary statistics extracted by two reviewers independently. The primary outcomes of our study were mild cognitive impairment, all-cause dementia, Alzheimer's disease, and vascular dementia. Heterogeneity was measured using the Q test and I2 statistic, and we used random-effects models with inverse-variance weighting to assess the association between adverse pregnancy outcome and primary outcomes with sufficient meta-analysable data via pooled adjusted HRs and 95% CIs. The study protocol was registered with PROSPERO, CRD42023453511. FINDINGS: Of 11 251 publications identified, 15 studies (including 7 347 202 participants) met inclusion criteria for the systematic review, and 11 studies (6 263 431 participants) had sufficient data for meta-analysis. A history of any adverse pregnancy outcome was associated with higher risk of all-cause dementia (adjusted HR 1·32 [95% CI 1·17-1·49]; I2= 80%), Alzheimer's disease (1·26 [1·04-1·53]; I2=63%), and vascular dementia (1·94 [1·70-2·21]; I2=0%). A history of any hypertensive disorder of pregnancy was significantly associated with all-cause dementia (1·32 [1·11-1·57]; I2=74%) and vascular dementia (1·78 [1·46-2·17]; I2=0%), but not Alzheimer's disease (1·24 [0·98-1·57]; I2=66%). Stillbirth was not significantly associated with higher risk of all-cause dementia (1·26 [95% CI 0·93-1·71]; I2=62%). In individual studies, similar effect directions were observed for preterm birth and fetal growth restriction, but data were insufficient for meta-analysis. INTERPRETATION: Given their increased risk of dementia, women with a history of adverse pregnancy outcomes should be evaluated for additional dementia risk factors and monitored closely for any signs of cognitive decline. Furthermore, to obtain more reliable findings, future studies should measure both exposures and outcomes prospectively and objectively. FUNDING: National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Institute on Aging, and National Heart, Lung and Blood Institute.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a těhotenství $7 D011247
650    12
$a kognitivní dysfunkce $x epidemiologie $x psychologie $7 D060825
650    12
$a demence $x epidemiologie $x psychologie $7 D003704
650    12
$a výsledek těhotenství $x epidemiologie $x psychologie $7 D011256
655    _2
$a časopisecké články $7 D016428
655    _2
$a systematický přehled $7 D000078182
655    _2
$a metaanalýza $7 D017418
700    1_
$a Conley, Patrick $u Department of Cardiology, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA
700    1_
$a Alirezaei, Mohammad $u Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Wolfova, Katrin $u Department of Neurology, Columbia University, New York, NY, USA; Department of Epidemiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Gonzales, Mitzi M $u Department of Neurology, Jona Goldrich Center for Alzheimer's and Memory Disorders, Cedars Sinai Medical Center, Los Angeles, CA, USA
700    1_
$a Tan, Zaldy S $u Department of Neurology, Jona Goldrich Center for Alzheimer's and Memory Disorders, Cedars Sinai Medical Center, Los Angeles, CA, USA
700    1_
$a Tom, Sarah E $u Department of Neurology, Columbia University, New York, NY, USA
700    1_
$a Yee, Lynn M $u Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL, USA
700    1_
$a Brickman, Adam M $u Department of Neurology, Columbia University, New York, NY, USA
700    1_
$a Bello, Natalie A $u Department of Cardiology, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA
773    0_
$w MED00209785 $t The lancet. Healthy longevity $x 2666-7568 $g Roč. 5, č. 12 (2024), s. 100660
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39675366 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104040 $b ABA008
999    __
$a ok $b bmc $g 2263089 $s 1239133
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 5 $c 12 $d 100660 $e 20241212 $i 2666-7568 $m The lancet. Healthy longevity $n Lancet Healthy Longev $x MED00209785
GRA    __
$a K23 HL136853 $p NHLBI NIH HHS $2 United States
GRA    __
$a K23 NS107645 $p NINDS NIH HHS $2 United States
GRA    __
$a R01 AG085475 $p NIA NIH HHS $2 United States
GRA    __
$a R01 NS122815 $p NINDS NIH HHS $2 United States
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...